ESOPMay 6, 2026, 04:52 PM
Milestone Scientific Reprices Executive Stock Options; Grants PRSUs
AI Summary
Milestone Scientific Inc.'s Compensation Committee approved a one-time stock option exchange program for its President/CEO and SVP, Global Head of Sales and Marketing. This program repriced eligible options, previously ranging from $0.46 to $0.50 per share, to a reduced exercise price of $0.31 per share, aligning with the closing price on April 30, 2026. The company also approved the grant of performance-based restricted stock units (PRSUs) to certain officers, with a total aggregate pool of 17,234,635 shares, subject to stockholder approval and achievement of performance milestones over a four-year period.
Key Highlights
- Executive stock options repriced to $0.31 per share for Eric Hines and Jason Papes.
- Original exercise prices for eligible options ranged from $0.46 to $0.50 per share.
- Total 4.0 million shares underlying repriced options, maintaining original share count.
- Vesting schedule modified for repriced options, increasing initial tranche to 500,000 shares (25%).
- Approved grant of performance-based restricted stock units (PRSUs) to certain officers.
- Aggregate pool for PRSUs is 17,234,635 shares, subject to stockholder approval.
- PRSU performance period is four years, from January 1, 2026, to December 31, 2029.
Price Impact
More from MLSS